Agency Information Collection Activities: Submission for OMB Review; Comment Request, 36238 [E9-17377]

Download as PDF 36238 Federal Register / Vol. 74, No. 139 / Wednesday, July 22, 2009 / Notices DEPARTMENT OF HEALTH AND HUMAN SERVICES Substance Abuse and Mental Health Services Administration Agency Information Collection Activities: Submission for OMB Review; Comment Request Periodically, the Substance Abuse and Mental Health Services Administration (SAMHSA) will publish a summary of information collection requests under OMB review, in compliance with the Paperwork Reduction Act (44 U.S.C. Chapter 35). To request a copy of these documents, call the SAMHSA Reports Clearance Officer on (240) 276–1243. Project: Mandatory Guidelines for Federal Workplace Drug Testing Programs (OMB NO. 0930–0158)— Extension SAMHSA’s Mandatory Guidelines for Federal Workplace Drug Testing Programs will request OMB approval for the Federal Drug Testing Custody and Control Form for Federal agency and federally regulated drug testing programs which must comply with the HHS Mandatory Guidelines for Federal Workplace Drug Testing Programs (69 FR 19644) dated April 13, 2004, and for the information provided by laboratories for the National Laboratory Certification Program (NLCP). The Federal Drug Testing Custody and Control Form is used by all Federal agencies and employers regulated by the Department of Transportation to document the collection and chain of custody of urine specimens at the collection site, for laboratories to report results, and for Medical Review Officers to make a determination. The Federal Drug Testing Custody and Control Form approved by OMB three years ago is being resubmitted for OMB approval without any revision. Prior to an inspection, a laboratory is required to submit specific information regarding its laboratory procedures. Collecting this information prior to an inspection allows the inspectors to thoroughly review and understand the laboratory’s testing procedures before arriving at the laboratory. The NLCP application form has not been revised compared to the previous form. The annual total burden estimates for the Federal Drug Testing Custody and Control Form, the NLCP application, the NLCP inspection checklist, and NLCP recordkeeping requirements are shown in the following table. Burden/ response (hrs.) Form/respondent Number of responses Total annual burden (hrs.) Custody and Control Form Donor .................................................................................................................................... Collector ................................................................................................................................ Laboratory ............................................................................................................................. Medical Review Officer ......................................................................................................... Laboratory Application ................................................................................................................. Laboratory Inspection Checklist .................................................................................................. Laboratory Recordkeeping .......................................................................................................... .08 .07 .05 .05 3.00 3.00 250.00 7,096,000 7,096,000 7,096,000 7,096,000 3 100 50 567,680 496,720 354,800 354,800 9 300 12,500 Total ...................................................................................................................................... ........................ ........................ 1,786,809 Written comments and recommendations concerning the proposed information collection should be sent by August 21, 2009 to: SAMHSA Desk Officer, Human Resources and Housing Branch, Office of Management and Budget, New Executive Office Building, Room 10235, Washington, DC 20503; due to potential delays in OMB’s receipt and processing of mail sent through the U.S. Postal Service, respondents are encouraged to submit comments by fax to: 202–395–6974. Dated: July 15, 2009. Dennis O. Romero, Deputy Executive Officer and Deputy Director, Office of Program Services. [FR Doc. E9–17377 Filed 7–21–09; 8:45 am] jlentini on DSKJ8SOYB1PROD with NOTICES BILLING CODE 4162–20–P VerDate Nov<24>2008 16:04 Jul 21, 2009 Jkt 217001 DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Government-Owned Inventions; Availability for Licensing National Institutes of Health, Public Health Service, HHS. ACTION: Notice. AGENCY: SUMMARY: The inventions listed below are owned by an agency of the U.S. Government and are available for licensing in the U.S. in accordance with 35 U.S.C. 207 to achieve expeditious commercialization of results of federally funded research and development. Foreign patent applications are filed on selected inventions to extend market coverage for companies and may also be available for licensing. ADDRESSES: Licensing information and copies of the U.S. patent applications listed below may be obtained by writing to the indicated licensing contact at the Office of Technology Transfer, National Institutes of Health, 6011 Executive PO 00000 Frm 00076 Fmt 4703 Sfmt 4703 Boulevard, Suite 325, Rockville, Maryland 20852–3804; telephone: 301/ 496–7057; fax: 301/402–0220. A signed Confidential Disclosure Agreement will be required to receive copies of the patent applications. High Diversity/High Affinity Domain Antibody Library Description of Invention: Available for licensing and commercial development is a highly diverse domain antibody (dAb) library providing antibodies that bind with high affinity to a variety of antigen targets. Antibody diversity is inherently limited by using only three CDRs of either light chain variable domain (LCDRs) or heavy chain variable domain (HCDRs). This novel dAb library is designed using light chain variable domain 3 (LCDR3) and heavy chain variable domain (HCDR3), which are of primary importance for creating binding site diversity in the human immune system. The library contains 2.5 × 10 10 dAbs. Human naturally occurring LCDR3s were grafted onto HCDR1 of m0. These antibodies are of very small size (15–17 kDa), high E:\FR\FM\22JYN1.SGM 22JYN1

Agencies

[Federal Register Volume 74, Number 139 (Wednesday, July 22, 2009)]
[Notices]
[Page 36238]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-17377]



[[Page 36238]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Substance Abuse and Mental Health Services Administration


Agency Information Collection Activities: Submission for OMB 
Review; Comment Request

    Periodically, the Substance Abuse and Mental Health Services 
Administration (SAMHSA) will publish a summary of information 
collection requests under OMB review, in compliance with the Paperwork 
Reduction Act (44 U.S.C. Chapter 35). To request a copy of these 
documents, call the SAMHSA Reports Clearance Officer on (240) 276-1243.

Project: Mandatory Guidelines for Federal Workplace Drug Testing 
Programs (OMB NO. 0930-0158)--Extension

    SAMHSA's Mandatory Guidelines for Federal Workplace Drug Testing 
Programs will request OMB approval for the Federal Drug Testing Custody 
and Control Form for Federal agency and federally regulated drug 
testing programs which must comply with the HHS Mandatory Guidelines 
for Federal Workplace Drug Testing Programs (69 FR 19644) dated April 
13, 2004, and for the information provided by laboratories for the 
National Laboratory Certification Program (NLCP).
    The Federal Drug Testing Custody and Control Form is used by all 
Federal agencies and employers regulated by the Department of 
Transportation to document the collection and chain of custody of urine 
specimens at the collection site, for laboratories to report results, 
and for Medical Review Officers to make a determination. The Federal 
Drug Testing Custody and Control Form approved by OMB three years ago 
is being resubmitted for OMB approval without any revision.
    Prior to an inspection, a laboratory is required to submit specific 
information regarding its laboratory procedures. Collecting this 
information prior to an inspection allows the inspectors to thoroughly 
review and understand the laboratory's testing procedures before 
arriving at the laboratory.
    The NLCP application form has not been revised compared to the 
previous form.
    The annual total burden estimates for the Federal Drug Testing 
Custody and Control Form, the NLCP application, the NLCP inspection 
checklist, and NLCP recordkeeping requirements are shown in the 
following table.

----------------------------------------------------------------------------------------------------------------
                                                                      Burden/
                         Form/respondent                             response        Number of     Total annual
                                                                      (hrs.)         responses     burden (hrs.)
----------------------------------------------------------------------------------------------------------------
Custody and Control Form
    Donor.......................................................             .08       7,096,000         567,680
    Collector...................................................             .07       7,096,000         496,720
    Laboratory..................................................             .05       7,096,000         354,800
    Medical Review Officer......................................             .05       7,096,000         354,800
Laboratory Application..........................................            3.00               3               9
Laboratory Inspection Checklist.................................            3.00             100             300
Laboratory Recordkeeping........................................          250.00              50          12,500
                                                                 -----------------------------------------------
    Total.......................................................  ..............  ..............       1,786,809
----------------------------------------------------------------------------------------------------------------

    Written comments and recommendations concerning the proposed 
information collection should be sent by August 21, 2009 to: SAMHSA 
Desk Officer, Human Resources and Housing Branch, Office of Management 
and Budget, New Executive Office Building, Room 10235, Washington, DC 
20503; due to potential delays in OMB's receipt and processing of mail 
sent through the U.S. Postal Service, respondents are encouraged to 
submit comments by fax to: 202-395-6974.

    Dated: July 15, 2009.
Dennis O. Romero,
 Deputy Executive Officer and Deputy Director, Office of Program 
Services.
[FR Doc. E9-17377 Filed 7-21-09; 8:45 am]
BILLING CODE 4162-20-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.